Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerated PACing for Improved Quality of lifE in Symptomatic Atrial Fibrillation Patients Undergoing Pace-and-ablate Strategy With Left Bundle Branch Area Pacing: a Randomized Controlled Pilot Trial: PACE-AF

NCT06377046 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06377046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06377046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerated PACing for Improved Quality of lifE in Symptomatic Atrial Fibrillation Patients Undergoing Pace-and-ablate Strategy With Left Bundle Branch Area Pacing: a Randomized Controlled Pilot Trial: PACE-AF
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2024
Completion date
May 31, 2026
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, pacemaker ddd, paroxysmal atrial fibrillation, permanent atrial fibrillation, persistent atrial fibrillation